The SH2 and SH3 binding partner AFAP-110 is a tyrosine phosphorylated substrate of Src. AFAP-110 has been hypothesized to link Src to actin ®laments, which may contribute to the eects of Src upon actin ®lament integrity. However, it has been unclear what eect activated Src (Src 527F ) has upon AFAP-110 structure or function and whether AFAP-110 plays a role in actin ®lament integrity. We report here that the carboxy terminal 127 amino acids of AFAP-110 are comprised of an a-helical region that contains a leucine zipper motif. This indicated the potential of AFAP-110 to selfassociate. Expression of the carboxy terminus as a fusion protein (GST-cterm) will permit anity absorption of cellular AFAP-110. The integrity of the a-helical leucine zipper motif in GST-cterm is required for anity absorption, but binding is not due to a classical leucine zipper interaction. Co-expression of Src 527F , unlike cSrc, will abrogate anity absorption of AFAP-110 with GST-cterm. These data indicate that Src 527F has aected a change in the carboxy terminal structure that renders AFAP-110 unavailable for anity absorption. Superose chromatography demonstrate that AFAP-110 will fractionate as a monomer or multimer, indicating AFAP-110 can be detected in a selfassociated form in cell lysates. Co-expression of Src 527F resulted in AFAP-110 fractionating with a molecular weight that predicts only a multimeric population. Deletional mutagenesis also indicate a biological role for the carboxy terminus in cellular localization and actin ®lament integrity. Deletion of the entire carboxy terminal a-helix (84 amino acids) will not permit AFAP-110 to eciently colocalize with actin ®laments or the cell membrane. Deletion of only the leucine zipper region of the carboxy terminal a-helix (44 amino acids) from AFAP-110 (AFAPA Dzip ) demonstrate that both AFAP Dlzip and actin ®laments are repositioned into rosette-like structures, similar to the eects of Src 527F , while co-expression of AFAP-110 with cSrc will not aect actin ®laments. These data indicate that AFAP-110 can play an important role in modulating actin ®lament integrity through carboxy terminal interactions that can be aected by Src .
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Introduction
The non-receptor tyrosine kinase pp60 c-src (cSrc) is maintained as an enzymatically repressed enzyme, in vivo (Cooper and Brown, 1996) . Transient activation of cSrc has been detected during the G 2 /M transition of the cell cycle, indicating that the tyrosine-speci®c protein kinase activity of cSrc is tightly controlled, and activation is likely to be important for progression through the cell cycle (Roche et al., 1995; Taylor and Shalloway, 1996) . Constitutive activation of cSrc is both necessary and sucient for transformation of primary or immortalized cell lines in culture and is characterized by morphological changes which are linked with the disruption of actin ®laments (Cooper and Brown 1996; Felice et al., 1990; Reynolds et al., 1989; Flynn et al., 1993) . The G 2 /M transition of the cell cycle is also linked with a relaxation of actin ®lament structures prior to the onset of mitosis (Jackson and Bellet, 1989) . Thus, one consequence of cSrc activation may be the concomitant disruption of actin ®laments, which in turn could in¯uence the phenotype of cells expressing activated variants of cSrc. Constitutive activation of cSrc has been detected in a number of human cancer cell lines as well (Rosen et al., 1986; Jacobs and Rubsamen 1983; Cartwright et al., 1989; Cartwright et al., 1990; Bolen et al., 1987; Staley et al., 1997) , indicating that cSrc activation may contribute to the phenotype of these cells. The concomitant disruption of actin ®laments is a hallmark for transformation by the Rous sarcoma virus encoded vSrc, or activated cSrc (Reynolds et al., 1989; Felice et al., 1990) . The mechanisms whereby activated cSrc (Src) aects cell growth and morphology are unknown; however, it has been hypothesized that phosphorylation of cellular substrates on tyrosine may modulate signal transduction pathways that in¯uence cell growth and transformation (Schaller et al., 1993) . Understanding the eects of Src upon cellular substrates will be an important step toward characterizing how this non-receptor tyrosine kinase can direct speci®c signals that modulate cell growth and transformation.
One model system for dissecting the molecular signals sent by Src is with the Src-binding partner and tyrosine phosphorylated substrate AFAP-110 (Actin Filament-Associated Protein, 110 kDa; Flynn et al., 1993; Flynn et al., 1995) . This SH2 and SH3 binding partner can form a stable complex with Src, in vivo, and stable complex formation is dependent upon the integrity of SH2 and SH3 interactions (Reynolds et al., 1989; Kanner et al., 1991; Flynn et al., 1993; Guappone and Flynn, 1997; Guappone et al., submitted) . It has been hypothesized that AFAP-110 may function by facilitating interactions between SH2 and/or SH3 containing proteins and actin ®laments , which may facilitate the eects of these proteins upon the actin-based cytoskeleton. The consequence of Src/AFAP-110 interactions is not well understood; however, AFAP-110 may be positioned to facilitate some of the eects of Src upon actin ®laments. Understanding the function of AFAP-110 and the eect Src may have upon it would clarify a role for this protein in Src-mediated signal transduction events and/or transformation of chick embryo ®broblast (CEF) cells.
One strategy for characterizing the function of AFAP-110 is to identify functional domains within the molecule (Figure 1 ). It has been noted that AFAP-110 contains two putative SH3 binding motifs , one of which facilitates interactions with Src, Fyn and Lyn Guappone and Flynn, 1997) . SH3 interactions between Src and AFAP-110 are important for presenting AFAP-110 for tyrosine phosphorylation (Kanner et al., 1991; Guappone and Flynn, 1997) . AFAP-110 also contains two SH2 binding motifs Guappone et al., submitted) . Lastly, AFAP-110 contains two pleckstrin homology (PH) domains that¯ank a target sequence for serine/threonine phosphorylation (Gibson et al., 1994; Shaw, 1996; Flynn et al., 1993) . Thus, the functional domain structure of AFAP-110 and its cellular localization indicate that this molecule could facilitate interactions between SH2/SH3 containing proteins, and possibly other signaling molecules, with the actin-based cytoskeleton.
Interestingly, a variant form of AFAP-110, called AFAP-120, was identi®ed in brain tissues (Flynn et al., 1995) . This brain-speci®c isoform contains an additional coding sequence that predicts 86 novel amino acids placed after Ser 510 called the novel insert (NINS, Figure 1 ). The NINS does not disrupt the reading frame of the carboxy terminal 127 amino acids common to AFAP-110 and are thus retained in AFAP-120 (Flynn et al., 1995) . These data indicate that the carboxy terminal 127 amino acids might encode an important domain, which may be required for the function of both AFAP-110 and AFAP-120. This report addresses the function of the carboxy terminal 127 amino acids in AFAP-110.
Results
The carboxy terminus of AFAP-110 contains a leucine zipper motif AFAP-120 is a variant form of AFAP-110 found predominantly in brain (Flynn et al., 1995) . This variant encodes an additional 258 bp of coding sequence which predict 86 novel amino acids, referred to as the novel insert or NINS (Flynn et al., 1995) . The NINS is positioned in the carboxy terminus 127 amino acids upstream of the TGA stop codon (Figure 1 ). Because the carboxy terminal 127 amino acids of AFAP-110 are also conserved in AFAP-120, it was hypothesized that this domain might be functionally signi®cant. A homology search revealed that there were two classes of proteins with homologous domains: cytoskeletal proteins and transcription factors (Table  1) . A closer examination of the homologies indicated the presence of a heptad leucine repeat between amino acids 553 ± 593, which was the only region of signi®cant homology. This structure has been referred to as a leucine zipper motif and has been well-characterized in amino acids 62 ± 71 ± SH3 binding motif I for Src, Fyn and Lyn, (c) amino acids 75 ± 84 ± SH3 binding motif II, (d) amino acids 85 ± 152 ± putative SH2 binding motif, (e) amino acids 153 ± 248 ± pleckstrin homology domain I, (f) amino acids 210 ± 360 ± target site for serine/threonine kinases, (g) amino acids 347 ± 450 ± pleckstrin homology domain II, (h) amino acids 450 ± 510 ± potential SH2 binding motif, (i) amino acids 511 ± 637 in AFAP-110 or amino acids 597 ± 723 in AFAP-120 ± carboxy terminal leucine zipper motif, (j) amino acids 511 ± 596 in AFAP-120 ± Novel Insert in AFAP-120, only 
Carboxy terminal interactions with AFAP-110 Y Qian et al transcription factors as well as some cytoskeletal proteins (Hurst, 1994; Busch and Sassone-Corsi, 1990 ). Neither AFAP-10 nor AFAP-120 has a strong basic region upstream of the leucine zipper motif and would not be predicted to bind DNA (data not shown).
Anity absorption of AFAP-110 from cell lysates with a GST-encoded fusion protein expressing the carboxy terminal 127 amino acids
The leucine zipper motif is a well-characterized mediator of protein-protein interactions (Busch and Sassone-Corsi, 1990 ). The homology data indicate that AFAP-110 may have the capability to associate with itself or other proteins through carboxy terminal interactions. To determine if AFAP-110 had the capability to self-associate, an anity absorption assay was performed using a GST-encoded fusion protein that expressed the carboxy terminal 127 amino acids of AFAP-110 (GST-cterm). A secondary structure prediction indicated that the ®rst 42 amino acids of the carboxy terminus (amino acids 511 ± 553) may exist as a combination of coils, b-sheath and turns, referred to as the`coil/turn region' (Figure 2a ). The carboxy terminal 84 amino acids are predicted to exist as a single a-helical structure with the leucine zipper motif at the amino terminal end of this a-helix (Figure 2a ). Four deletion variants of GST-cterm were also created, and these fusion proteins were used to evaluate the determinants for anity absorption of cellular AFAP-110 ( Figure 2a ). The fusion proteins were immobilized on glutathione-coated sepharose beads and incubated with Cos-1 cell lysates overexpressing AFAP-110. The data demonstrate that GST-cterm, GST-CT D42 and GST-CT D44 were capable of anity absorbing cellular AFAP-110 (Figure 2b ), while GST alone is unable to anity absorb AFAP-110 ( Figure 2b ). The slight decrease in anity absorption by GST-CT
D42
, and the slight increase in anity absorption eciency by GST-CT D44 might indicate a structural or regulatory role for these regions in anity absorption. The band detected below AFAP-110 is likely a proteolytic breakdown product, as previously hypothesized (Flynn et al., 1995) . GST-CT Dlzip was de®cient in binding cellular AFAP-110, while GST-CT D84 was unable to anity absorb AFAP-110 altogether ( Figure 2b ). These data indicate that the a-helical region, containing the leucine zipper motif, is important for anity absorption. Thus, AFAP-110 does have the capability to self-associate through carboxy terminal interactions and the integrity of the a-helical region is required for anity absorption.
Leucine zipper motifs function by forming a hydrophobic interaction with other similar or identical leucine zipper motifs (Busch and Sassone-Corsi, 1990 ). To determine whether anity absorption of AFAP-110 by GST-cterm was being modulated by hydrophobic interactions de®ned by a classical leucine zipper interaction, or due to other interactions de®ned in the a-helix, point mutations were generated that changed the leucine residues which are an integral part of the heptad repeat to a arginine and/or a proline. Leu 581 is the third leucine within the heptad repeat and this residue was mutated to Pro within The carboxy terminus of AFAP-110 can modulate dimer formation. (a) The carboxy terminus is comprised of two distinct secondary structures. Amino acids 511 ± 553 predict a region of coils and turns, while amino acids 554 ± 637 predict an a-helix (I). Positioned at the amino terminal half of the a-helix is the leucine zipper motif (lzip). Fusion proteins used for anity absorption were designed based upon the secondary structure. Sequences encoding polypeptides represented in the carboxy terminus of AFAP-110 were ampli®ed by PCR and subcloned into pGex-2T, (II) GST-cterm expresses amino acids 511 ± 637 of AFAP-110, (III) GST-CT D42 expresses amino acids 553 ± 637, (IV) GST-CT D44 expresses amino acids 511 ± 593, (V) GST-CT Dlzip contains a deletion that removes amino acids 554 ± 592, including the majority of the leucine zipper motif which is de®ned by amino acids 564 ± 598 and (VI) GST-CT D84 expresses amino acids 511 ± 553. (b) Anity absorptions from Cos-1 cell lysates overexpressing AFAP-110. AFAP-110 was overexpressed in Cos-1 cells and anity absorbed with the GST-encoded fusion proteins, as indicated in lanes 2 ± 7. Lane 1, 25 mg cell lysate overexpressing AFAP-110 was resolved for comparison. Proteins were resolved by 8% SDS ± PAGE and Western blot analysis was carried out with mAb 4C3. del refers to D or deletion. (c) Anity absorption of AFAP-110 does not occur through a classical leucine zipper interaction. Site-directed mutagenesis was employed to mutate one or two leucine residues to an arginine and/or a proline residue within GST-cterm. AFAP-110 was overexpressed in Cos-1 cells and the lysates divided into equal parts for aninty absorption with GST-cterm or the mutated GST-cterm constructs. Absorbed AFAP-110 was analysed by Western blot with mAb 4C3 ). This point mutation would be predicted to initiate a short turn in the ahelical structure. In addition, Leu 574 , the second leucine residue in the heptad repeat, was changed to an Arg within GST-cterm (GST-cterm L574R/L581P ). This change would be predicted to abrogate the hydrophobic interaction normally modulated by that leucine residue in the heptad repeat. AFAP-110 was overexpressed in Cos-1 cells and an anity absorption assay attempted. GST-cterm was able to anity absorb AFAP-110 as well as GST-cterm L581P and GST-cterm L574R/L581P ( Figure  2c ). These data indicate that anity absorption of AFAP-110 was not accomplished via hydrophobic interactions de®ned by a classical leucine zipper interaction. Thus, anity absorption may be modulated by a distinct interaction within the carboxy terminal a-helix.
Co-expression of Src 527F , but not cSrc, prevent GSTcterm from absorbing AFAP-110 from Cos-1 cell lysates An anity absorption assay was performed to determine whether co-expression of Src 527F or cSrc might aect the ability of GST-cterm to anity absorb cellular AFAP-110. AFAP-110 was transiently expressed in Cos-1 cells alone, co-expressed with either cSrc or with an activated variant of cSrc, Src 527F (Figure 3), as previously described (Guappone et al., 1996) . AFAP-110 was immunoprecipitated and the steady-state levels of tyrosine phosphorylation quantitated with rabbit anti-phosphotyrosine. The data demonstrate that equivalent amounts of AFAP-110 were immunoprecipitated from Cos-1 cell lysates expressing AFAP-110 alone, AFAP-110 and cSrc, or AFAP-110 and Src 527F (Figure 3a) . Src 527F and cSrc were able to direct signi®cantly high steady-state levels of tyrosine phosphorylated AFAP-110 while expression of AFAP-110 in the absence of Src 527F did not permit signi®cant tyrosine phosphorylation of this protein (Figure 3b ). Anity absorption with GST-cterm demonstrate that AFAP-110 can be absorbed when expressed alone or when co-expressed with cSrc; however, AFAP-110 that had been co-expressed with Src 527F was resistant to anity absorption ( Figure 3c ). Both cSrc and Src 527F are able to phosphorylate AFAP-110 on tyrosine (Figure 3b ). In addition, the population of AFAP-110 absorbed with GST-cterm in the presence of cSrc demonstrates signi®cant steadystate levels of tyrosine phosphorylation, unlike AFAP-110 that had been expressed alone (Figure 3d ). These data indicate that Src 527F , and not cSrc, might direct a molecular event that aects the structure of AFAP-110 and prevents anity absorption with GST-cterm. This molecular event may be independent of tyrosine phosphorylation of AFAP-110; however, it is possible that Src 527F has phosphorylated a tyrosine residue in AFAP-110 that was not phosphorylated by cSrc, and this in turn could be responsible for the changes in AFAP-110 that prevent anity absorption with GSTcterm.
AFAP-110 can exist as a monomer or meltimers in cell lysates
Anity absorption of AFAP-110 from cell lysates indicate that it may have the potential to exist as a monomer or multimer, in vivo. To test this, Cos-1 cell lysates expressing AFAP-110 were resolved by gel ®ltration. Here, FPLC and a Superose 6 10/30 column were used to collect fractions of cell lysates. This column will permit resolution of protein complexes with molecular weights ranging from 29 kDa to 500 kDa. Although AFAP-110 has a M r of 110 kDa by SDS ± PAGE, its actual molecular weight is predicted to be 72 315 Da (Flynn et al., 1995) . Therefore, fractionation of the Cos-1 cell lysates by gel ®ltration would be predicted to identify AFAP-110 based on this molecular weight. Nineteen 400 ml fractions were collected and 100 ml of each fraction was resolved by 8% SDS ± PAGE, followed by Western blot analysis for AFAP-110 (Figure 4a ). The data indicate that AFAP-110 can be detected in two major Relative scanning densitometric numbers were normalized to the peak fraction densitometry number (i.e., the darkest band from each analysis). Fractionation of molecular weight (MW) standards are shown in kDa beneath the fraction where eluted can be discerned. The ®rst peak predicts a multimeric population of AFAP-110 that would be represented by fractions 7 ± 12 with a molecular weight ranging from approximately 410 to 150 kDa. The peak fractions (8 and 9) correlate with a molecular weight of approximately 250 kDa.
These peaks predict a multimeric form of AFAP-110 that could be represented by dimeric to hexameric complexes of AFAP-110, with fractions 9 and 10 predicting a tetramer. It is not clear whether fractions 11 and 12 represent a true shoulder adjacent to the multimeric peak. Visual inspection of fractions 8 through 12 indicate roughly equal amounts of AFAP-110. Thus, a broad peak could be predicted, with a possible shoulder de®ned by fractions 11 and 12. A distinct peak is also revealed with fractions 16 ± 18 and predicts a molecular weight of approximately 70 ± 42 kDa. This approximates the molecular weight of AFAP-110 and likely re¯ects a monomeric population of AFAP-110. The peak shown with fraction 14 (Figure 4d ) is likely an artifact. The Western blot has an unde®ned shadow in this area which was read by scanning densitometry (Figure 4b ). Lastly, fractionation of Cos-1 cell lysates did not permit detection of endogenous AFAP-110 by this method (data not shown). These data indicate that AFAP-110 can be detected in a self-associated form in NP-40 Cos-1 cellular lysates.
Gel ®ltration of Cos-1 cell lysates containing both AFAP-110 and Src 527F revealed a dierent pro®le (Figure 4b ). Here, AFAP-110 is found in a single peak (fractions 8 ± 12) that predicts a molecular weight of approximately 340 ± 150 kDa (Figure 4b ). Interestingly, a second peak that would predict a monomeric population of AFAP-110 was not detected. In addition, the M r of AFAP-110 has changed. Fraction #19 from the gel ®ltration of AFAP-110 expressed alone is resolved on the lane marked ** (Figure 4b ) and demonstrates that when co-expressed with Src 527F , AFAP-110 has a slightly retarded M r and is detected as a single band, rather than a doublet, compared to AFAP-110 expressed alone. This slightly retarded M r may re¯ect a post-translational modi®cation. Stripping and reprobing of this Western blot with a monoclonal antibody speci®c for the avian form of Src demonstrate that Src 527F is found in fraction 10 (Figure 4c ), which predicts a molecular weight of approximately 240 kDa (Figure 4d) causes a signi®cant reduction in the monomeric population of AFAP-110, relative to the multimeric population.
The integrity of the carboxy terminal a-helix in¯uences cellular localization of AFAP-110
An experiment was designed to determine whether the integrity of the carboxy terminal a-helical domain could in¯uence subcellular localization. Here, two deletion variants of AFAP-110 were created that lacked either (a) the entire carboxy terminal a-helix (AFAP (Figure 6e and f). These data demonstrate that AFAP-110 will colocalize with actin ®laments when expressed alone (Figure 6a and b) when co-expressed with Src 527F or cSrc (Figures 6c ± f) . Src 527F will cause a disruption of actin ®lament structures, repositioning AFAP-110 and actin ®laments into rosette-like structures, similar to earlier ®ndings in CEF cells . cSrc does not cause a strong repositioning of AFAP-110 or actin ®laments into rosette-like structures. There was some evidence for small rosette formation with cSrc; however the number and size of the rosettes were fewer and smaller, per transfected cell. The AFAP D84 deletion variant was also expressed in the absence of Src (Figure 6g and h) , as was AFAP Dlzip (Figure 6i and j). AFAP D84 was unable to eciently co-localize with actin ®laments or the cell membrane. This protein was consistently found in the cytoplasm and exhibited a diuse staining pattern, indicating that the integrity of the carboxy terminal a-helix is important for colocalization with actin ®laments and the cell membrane. Interestingly, deletion of only the leucine zipper motif resulted in a redistribution of both AFAP Dlzip and actin ®laments into rosette-like structures (Figure 6i and j) , similar to the eects of Src 527F upon actin ®laments (Figure 6c and d) . These data indicate that the carboxy terminus can play an important role in actin ®lament and cell membrane associations, and that removal of only the a-helical region containing the leucine zipper motif will aect a change in actin ®lament integrity, not unlike the eects of Src 527F . c, e, g, i) or for actin ®lament integrity (b, d, f, h, j) . Overexpressed AFAP-110 was analysed using Ab F1 and donkey anti-rabbit antibodies conjugated to Texas Red (Sigma). Actin ®laments were visualized with FITC-conjugated phalloidin (Sigma). Images were acquired using a Zeiss confocal microscope and represent a single plane of scanning
Discussion
The presence of a conserved a-helical region containing a leucine zipper motif indicated that AFAP-110 had the potential to self-associate through interactions involving the carboxy terminus. Therefore, the experiments in this report sought to determine if AFAP-110 could self-associate and whether Src could aect the formation of these complexes, as a model for understanding the function of this domain. The GST-cterm fusion protein was capable of anity absorbing cellular AFAP-110 from Cos-1 cell lysates and the integrity of the carboxy terminal 84 amino acids is necessary for anity absorption by GST-cterm. Therefore, the carboxy terminal a-helix contains sucient sequence information to permit anity absorption. However, anity absorption is not mediated by a classical leucine zipper interaction. Leucine zipper domains play a well-documented role in facilitating homodimer and heterodimer formation with many dierent proteins, including transcription factors (Hurst, 1994) , cellular kinases (Ruth et al., 1997; Gamm et al., 1995; Kitigawa et al., 1995) , transmembrane receptors (Saras et al., 1994; Klein et al., 1993; Rodrigues and Park, 1993; Chen et al., 1993; Earl et al., 1993) and cytoskeletal proteins (Klein et al., 1993; Bikle et al., 1996; Pearlman et al., 1994; Ward and Kirshner, 1990; Maekawa and Kuriyama, 1993) . The mechanism for dimer formation by leucine zippers requires hydrophobic interactions between opposing leucine residues in the heptad repeats, which may be stabilized by charge interactions (Hodges, 1992) . Mutagenesis of one or two of the leucine residues to a proline, or a proline and an arginine, was not sucient to disrupt anity absorption with GST-cterm. The proline mutation would have been predicted to disrupt a leucine zipper interaction by introducing a turn in the a-helix at the third leucine residue in the heptad repeat, while the arginine mutation would be predicted to disrupt hydrophobic interactions modulated by the second leucine residue in the heptad repeat. Therefore, anity absorption by GST-cterm may not occur through a classical leucine zipper interaction. We predict that anity absorption is mediated by unidenti®ed sequences within the carboxy terminal a-helix. It should be noted that other motifs within the carboxy terminus may also be important for anity absorption. Although the coil/turn region (amino acids 511 ± 553) was not solely sucient to permit GST-CT D84 to absorb cellular AFAP-110, GST-CT
D42
, which lacks the coil/ turn region, consistently demonstrated a slightly reduced ability to bind cellular AFAP-110. It may be that the coil/turn region facilitates presentation of the binding motif. GST-CTA Dlzip was capable of weakly absorbing AFAP-110, indicating that amino acids 594 ± 637, which de®ne the very carboxy terminal ahelix, may also contribute to anity absorbing AFAP-110, albeit weakly. It is possible that the leucine zipper region of the a-helix could play either a direct role or an indirect role in anity absorption. A direct role predicts that the binding motif exists within the ahelical region de®ned by the leucine zipper region. An example of an indirect role might be provided by controlling self-association through a regulatory function. It is noteworthy that the carboxy terminal 127 amino acids has a net charge of +10, and the leucine zipper region contributes most of this positive charge (+8). It is possible that charge repulsion could destabilize multimers enough to permit anity absorption, while removal of this region might indirectly stabilize the GST-cterm fusion protein as a multimer, or AFAP-110 as a multimer, and this could impede anity absorption. It will be important to determine (1) the exact amino acids that act as the binding site within GST-cterm, (2) the exact location of the corresponding binding sites within AFAP-110 and (3) the role of the leucine zipper region in anity absorption.
Interestingly, GST-cterm could not anity absorb AFAP-110 when it was co-expressed with Src 527F . In Cos-1 cells, the same plasmid vector encodes both AFAP-110 and Src 527F , ensuring that both gene products are expressed in the same transfected Cos-1 cells (Guappone et al., 1996) . This system enables high expression levels of AFAP-110 and Src
527F
, and permits tyrosine phosphorylation of AFAP-110 as well as stable complex formation with Src 527F , much as seen in Src 527F transformed CEF cells Guappone et al., 1996; Guappone and Flynn, 1997) . The fact that GST-cterm was unable to anity absorb AFAP-110 expressed in the presence of Src 527F indicates that this tyrosine kinase may have directed a molecular event which alters the structure of the carboxy terminus and precludes anity absorption. This molecular mechanism is unclear, although there are at least three possibilies: (1) Tyrosine phosphorylation may have altered the structure; however, it could be argued that tyrosine phosphorylation of AFAP-110 may not be responsible as co-expression of cSrc was unable to prevent anity absorption of cellular AFAP-110. On the other hand, it is possible that one or more speci®c tyrosine residues need to be phosphorylated in order to abrogate anity absorption by GST-cterm, and that these same tyrosine residues are only phosphorylated by Src 527F , and not by cSrc. (2) Stable complex formation may be responsible for preventing anity absorption of AFAP-110. Mutant forms of Src 527F and AFAP-110 that fail to form a stable complex will be required to determine the role of stable complex formation in abrogating anity absorption. (3) A third mechanism may be possible whereby Src 527F indirectly activates another molecule which in turn aects AFAP-110 structure, rendering it unsusceptible to anity absorption. An example might be through ser/thr phosphorylation. Src 527F and vSrc will activate some cellular ser/thr kinases (Blenis and Ericson, 1985; Blenis et al., 1987; Sturgill et al., 1988; Morrison, 1988; Spangler et al., 1989; Nori et al., 1990; Qureshi et al., 1991; Sternberg et al., 1993) . AFAP-110 is a substrate for ser/thr phosphorylation and demonstrates increased levels of ser/thr phosphorylation in the presence of Src 527F Kanner et al., 1991) . Experiments that address the mechanism by which Src 527F abrogates anity absorption of AFAP-110 by GST-cterm are in progress.
The anity absorption assays predicted that AFAP-110 might self-associate, in vivo. Gel ®ltration of transiently transfected Cos-1 cell lysates con®rm that AFAP-110 can be detected in a fraction that predicted either a multimer or a monomer. The molecular weight of AFAP-110 is 72 315 Da and a peak can be resolved from FPLC fractions that indicate AFAP-110 is eluted as a monomer with a fraction that predicts a molecular weight of approximately 70 ± 42 kDa. This slight dierence in molecular weight could be due to the shape of AFAP-110 and how it may resolve through the Superose 6 10/30 column. Interestingly, AFAP-110 was also identi®ed in a fraction that predicts a multimer (two to six molecules of AFAP-110 in complex). Although this multimeric complex may contain proteins other than overexpressed AFAP-110, it is important to point out that the overexpression levels of AFAP-110 are quite high, estimated at approximately 10 6 molecules/transfected cell (Guappone et al., 1996; Guappone and Flynn, 1997) . Thus, we predict that the majority of these multimers represent self-associations involving AFAP-110, and contributions from Cos-1 cellular proteins may not be as signi®cant, although we cannot rule out the possibility that other Cos-1 cellular proteins formed associations with AFAP-110 after cell lysis. These data predict that AFAP-110 does have the capability to form a multimer, most likely by self-associating.
Identi®cation of the precise amino acids that modulate both multimer formation and anity absorption are in progress.
In the presence of Src 527F AFAP-110 was only detected among a single peak fraction that predict a multimer, with a molecular weight of approximately 350 ± 150 kDa. These data indicate that Src 527F may induce AFAP-110 to self-associate, as no monomeric fraction was detected. Src 527F was also found in the AFAP-110 multimeric fraction. Because Src 527F will form a stable complex with AFAP-110, these data indicate that either two molecules of Src 527F and two molecules of AFAP-110 (dimer), or three molecules of AFAP-110 (trimer) and one molecule of Src 527F are in complex in fraction 10 (molecular weight approximately 240 kDa). Three molecules of Src 527F and one molecule of AFAP-110 are an unlikely combination, as one molecule of AFAP-110 only has the potential to bind one or two molecules of Src 527F (Guappone and Flynn, 1997; Guappone et al., submitted) . It is also possible that greater resolution of the peaks may reveal a subpopulation of AFAP-110 that is not in stable complex with Src 527F , and would be predicted to exist as a tetramer, which would fractionate coincident with the Src 527F /AFAP-110 stable complex. These data indicate that Src 527F may have changed AFAP-110 in two ways: (1) co-expression of Src 527F did not permit detection of AFAP-110 in a separate peak fraction that would predict a signi®cant monomeric population and (2) AFAP-110 resolves as a single band with a slightly retarded M r when co-expressed with Src 527F , compared to expression alone. These data indicate that stable complex formation with Src 527F may result in either (a) preferential binding to the monomeric population, followed by induction of multimerization or (b) disruption of larger multimers such that an AFAP/ Src 527F complex would be composed of two molecules of AFAP-110 and two molecules of Src With regard to the M r , it should be noted that a change in M r was not demonstrated in Figure 3a . This may be due to the amount of AFAP-110 resolved in that experiment, or minor dierences in gel conditions. Changes in AFAP-110 M r in the presence of Src 527F have been detected previously but are less apparent when signi®cantly higher amounts of AFAP-110 are resolved by 8% SDS ± PAGE (Flynn unpublished data) .
Most signi®cantly, the integrity of the carboxy terminus will also aect the subcellular localization of AFAP-110 and the integrity of actin ®laments, indicating a biological function for this domain. In CEF cells, AFAP-110 co-localizes with actin ®laments and expression of Src 527F will reposition both AFAP-110 and actin ®laments into rosette-like structures, coincident with transformation . Similarly, the data presented here demonstrate that expression of AFAP-110 in Cos-1 cells will also permit ecient co-localization with actin ®laments. Src 527F will disrupt actin ®laments in Cos-1 cells and overexpressed AFAP-110 maintains an association with the disrupted actin ®laments. cSrc does not aect actin ®lament integrity in either CEF cells (Reynolds et al., 1989) or in the Cos-1 cells used in this study and AFAP-110 maintains its association with actin ®laments in the presence of cSrc. The mechanism by which AFAP-110 binds to actin ®laments and the cell membrane is dependent upon interactions within the carboxy terminal a-helix. Deletion of the carboxy terminal ahelix repositions AFAP D84 into a diuse staining pattern in the cytoplasm and will no longer permit interactions with the cell membrane or actin ®laments. Interestingly, deletion of only the leucine zipper motif (amino acids 553 ± 593) revealed a dierent result. Here, AFAP Dlzip retained an association with actin ®laments; however, both AFAP Dlzip and actin ®laments were repositioned into rosette-like structures, similar to the eects of Src 527F upon AFAP-110 and actin ®laments. Because deletion of the a-helical region that contains the leucine zipper motif is not sucient to remove AFAP-110 from actin ®laments, these results indicate that actin ®lament association might be achieved through the a-helical 44 amino acids (amino acids 594 ± 637). Further deletional analysis will be required to demonstrate this. The appearance of AFAP Dlzip and actin ®laments in rosette-like structures was very similar to the aect Src 527F had upon AFAP-110 and actin ®lament localization in either Cos-1 cells or CEF cells (Reynolds et al., 1989; Flynn et al., 1993) . These results indicate that AFAP-110 may play an important role in modulating actin ®lament integrity in response to activated Src. In addition, the integrity of the leucine zipper motif may be central to this role. It is possible that the ability of Src 527F to disrupt actin ®laments may be facilitated in part by signals that target the structure and function of the carboxy terminal a-helix in AFAP-110.
Materials and methods

Cell culure in vivo expression and immuno¯uorescence localization
Cos-1 cells were maintained in DMEM containing 5% fetal calf serum, 2 mM glutamine and 1% penicillin/streptomycin. Transfection of pCMV-1 plasmid constructs into Cos-1 cells was carried out according to the method of Chen and Okayama, (1987) .
pCMV-1 constructs containing pp60 527F and/or AFAP-110 were generated as previously described (Guappone et al., 1996) . AFAP D84 encodes Met 1 -Tyr 553 and lacks the carboxy terminal 127 amino acids. AFAP D84 was created by generating a stop codon by site-directed mutagenesis. Sequence analysis con®rm the presence of this stop codon and the integrity of anking sequences. The carboxy terminus was sequenced in its entirety and subcloned into AFAP-110, to ensure that no spurious mutations could be present. AFAP-110 D84 was subcloned from pBluescript KS+ into pCMV-1 using the KpnI and ZbaI restriction sites, similar to the cloning of AFAP-110 into pCMV-1 (Guappone et al., 1996) . AFAP Dlzip lacks the leucine zipper motif. Deletion of the leucine zipper motif was accomplished by generating a second BglII restriction site in the carboxy terminus by site directed mutagenesis. The mutations did not aect the coding sequence outside of the deleted leucine zipper motif. The BglII site was engineered at bp 1689 (using the AFAP-110 sequence numbering system ± accession number L20303). A second BglII site exists at bp l798. Digestion with BglII and religation removed bp 1689 ± 1798 and created pCMV AFAPDlzip , which lacks amino acids 554 ± 598. The leucine zipper motif is de®ned by amino acids 564 ± 593.
For immuno¯uorescence analysis, transfected cells were grown on coverslips. Sixty to 66 h post-transfection, the transfected Cos-1 cells were ®xed with 3.7% formaldehyde, 30 min, 48C. The cell membranes were permeabilized with 0.1% Triton X-100, 4 min, 218C. Immuno¯uorescence localization of transiently expressed AFAP-110 or AFAP-110 D84 was accomplished using Ab F1, as previously described . Concentrations of Ab F1 were reduced to 1 mg/ml to preferentially image transiently expressed proteins and not Cos-1 cellular AFAP-110, by immunofluorescence. Ab F1 was detected with donkey a-rabbit TRITC (Sigma). Actin ®laments were imaged using FITC-phalloidin (Sigma). After the ®nal wash, the coverslips were mounted on slides for image analysis. Immuno¯uorescence images for actin ®laments, AFAP-110, AFAP D84 and AFAP Dlzip were acquired and analysed in the WVU Anatomy department Image Analysis Lab using a Zeiss confocal microscope and scanning dierent planes of the cell. Images presented re¯ect single scanned planes. The images were collected as color and reprocessed for black and white.
Generation of GST encoded fusion proteins and anity absorption pGex-cterm was created by PCR ampli®cation (with engineered BamHI and EcoRI restriction sites at the end of each primer) of the coding sequence in AFAP-110 encoding Phe 511 to Asp 637 and was subcloned into the novel BamHI and EcoRI sites in pGex-2T. Similarly, deletion variants of the GST-cterm were created by PCR amplification of the speci®ed region and subcloned into pGex-2T via the unique BamHI and EcoRI sites. Deletion of the leucine zipper motif in pGex-cterm was accomplished by engineering a BglII site at bp 1689 ± 1693 (using the AFAP-110 sequence numbering system ± accession number L20303) in pGex-cterm. Creation of this new BglII site required sitedirected mutagenesis of bp 1689 from G?A and at bp 1680 A?G. A second BglII site exists at bp 1798. Digestion with BglII and religation removed bp 1689 ± 1798, which removes amino acids 558 ± 593. All constructs were veri®ed by sequence analysis over the ampli®ed region. The preparation of bacterial lysates containing these fusion proteins as well as immobilization of the fusion proteins to glutathione-coated sepharose beads, was accomplished as previously described (Guappone et al., 1996) . All immobilized fusion proteins were quantitated before absorption by resolving the immobilized protein on a 12% SDS ± PAGE and quantitating by Coomassie staining. Twenty mg of fusion protein were immobilized upon 100 ml glutathione-coated sepharose beads (50% slurry, Pharmacia). Cell Iysates were prepared with NP-40 lysis buer (1% NP-40; 50 mM Tris, pH 7.5; 150 mM NaCl; 2 mM Sodium Vanadate; 2 mM PMSF; 50 mg/ml aprotinin; 2 mM EGTA). Lysis buers containing ionic detergents, e.g., RlPA containing SDS and/or 0.25% deoxycholate, did not permit ecient and reproducible anity absorptions (data not shown).
Immobilized fusion proteins were incubated with 100 mg Cos-1 cell lysates (0.2 mg/ml) for 1 h, 48C, while rotating on an orbital shaker. Immobilized cellular proteins were washed twice with NP-40 lysis buer (200 ml) and twice with trisbuered saline (200 ml; 50 mM tris, pH 7.5; 150 mM NaCl), then eluted by adding 50 ml 26Laemmli sample buer and boiling for 3 ± 5 min. The solubilized proteins were separated from the sepharose beads by centrifugation, and resolved by SDS ± PAGE, as previously described (Guappone et al., 1997; Flynn et al., 1995) .
FPLC analysis and gel ®ltration
Gel ®ltration of Cos-1 cellular lysates was accomplished using a Superose 6 10/30 chromatography column and FPLC. The column was equilibrated with 1% NP40 lysis buer and molecular weight standards were run independently of each other, using dimeric Jack Bean Urease, Alcohol dehydrogenase, dimeric BSA, ovalbumin, dimeric carbonic anhydrase and b-amylase as standards. Onehundred ml of transfected Cos-1 cellular lysates was injected into the column. This represents approximately 1/10 th ofthe total cell lysate obtained from a 100 mm plate (approximately 100 mg of total cellular protein lysate or I ± 5*10 5 cell equivalents). Fractions were collected every 2 min (0.4 ml/fraction with a¯ow rate of 0.2 ml/min), beginning after 12 mls of buer had been eluted through the column. One-hundred ml from each fraction were resolved by 8% SDS ± PAGE and probed for the presence of AFAP-110 by Western blot analysis with Ab F1.
Protein characterization and analysis
The monoclonal antibody 4C3 was used as previously described and the polyvalent antibody (Ab) F1 was prepared as previously described . Isolation of immune complexes, Western transfer and Western blot analysis with Ab F1 were done as previously described . Bound primary antibody was quantitated using an HRP-conjugated secondary antibody followed by detection using chemiluminescence.
